
BIOVAXYS TECHNOLOGY CORP by BioVaxys Technology fell 50.8% from $0.18 to $0.09, behind the S&P 500's +10.8%. Its worst day was Oct 7 (−37.1%), and its low came Apr 21 at $0.03.
Nov 12, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
BIOVAXYS TECHNOLOGY CORP by BioVaxys Technology closed at its highest level of the year, 12.2% above where the year started.
+6.8% · S&P 500 +1.0%
BIOVAXYS TECHNOLOGY CORP by BioVaxys Technology closed at its lowest level of the year, 82.2% below where the year started.
Story events cover the past 12 months · Times ET
−18.9% · S&P 500 −0.7%
BIOVAXYS TECHNOLOGY CORP by BioVaxys Technology shares rose 43.0%, while the S&P 500 rose 0.6%.
+43.0% · S&P 500 +0.6%
BIOVAXYS TECHNOLOGY CORP by BioVaxys Technology shares rose 47.8%, while the S&P 500 rose 0.8%.
+47.8% · S&P 500 +0.8%
BIOVAXYS TECHNOLOGY CORP by BioVaxys Technology shares rose 55.8%, while the S&P 500 fell 0.2%.
+55.8% · S&P 500 −0.2%
BIOVAXYS TECHNOLOGY CORP by BioVaxys Technology shares rose 87.9%, while the S&P 500 fell 0.5%.
+87.9%, the year's best day · S&P 500 −0.5%
BIOVAXYS TECHNOLOGY CORP by BioVaxys Technology shares rose 54.4%, while the S&P 500 rose 0.7%.
+54.4% · S&P 500 +0.7%
Where it ended: a close of $0.09 on Nov 12, 2026.
Nothing in the past 12 months.
All BVAXF earningsNothing in the past 12 months.
All BVAXF analyst actionsNothing in the past 12 months.
All BVAXF dividend historyNothing in the past 12 months.
All BVAXF news